4D Molecular Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | 67.6% | 67.6% | -84.7% |
| FY2020 | -22.1% | -22.1% | -19.7% |
| FY2021 | -22.3% | -22.3% | -20.2% |
| FY2022 | -46.5% | -46.5% | -41.1% |
| FY2023 | -32.8% | -32.8% | -29.7% |
| FY2024 | -31.5% | -31.5% | -28.7% |
| FY2025 | -27.7% | -27.7% | -24.7% |